Top 24 Vor Biopharma investors
The most complete profiles first. Showing 24 of 24.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Louis BernemanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Manny StockmanVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Robert AdelsonVerified
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 65 more
Verified email available
Anurag AgarwalVerified
Venture Capital, University Program, Entrepreneurship Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Matt CohenVerified
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Verified email available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Marc Singer
Venture Capital, University Program, Entrepreneurship Program · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 69 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
William Harrington
Venture Capital, University Program, Investor · United States
Series AHealth CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Kirsten Leute
Venture Capital, University Program · United States
Health CareGeneticsPaymentsCybersecurityPortfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 64 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Vor Biopharma investors are on Angel Roster?
Angel Roster lists 24 Vor Biopharma investors. 12 of them (50%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (24), Private Equity Firms (11) and University Program Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Vor Biopharma investors invest in?
Among those that list a stage, the most common are Seed (11) and Series A (5).
Where are Vor Biopharma investors based?
Most are based in the United States (24).
Which companies have Vor Biopharma investors backed?
The most-backed portfolio companies among them are Cleave Therapeutics (24), Escient Pharmaceuticals (24), Millendo Therapeutics (24), Homology Medicines (24) and Ceterix Orthopaedics (16).
How do I contact Vor Biopharma investors?
Create a free Angel Roster account to search and filter all 24, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.